U.S. Announces Negotiated Prices for 15 Drugs Under Medicare

The New York TimesWednesday, November 26, 2025 at 6:15:33 PM
U.S. Announces Negotiated Prices for 15 Drugs Under Medicare
  • The Trump administration has announced negotiated prices for 15 drugs under Medicare, which could have saved the program $12 billion last year, reducing spending on these medications by 44%. The list includes popular inhalers like Breo Ellipta and treatments for various conditions including cancer and diabetes.
  • This development is significant for Medicare as it aims to lower prescription drug costs for beneficiaries, potentially improving access to essential medications and alleviating financial burdens on the healthcare system.
  • However, the announcement comes amid rising healthcare costs, with projections indicating that Medicare Part B premiums are set to exceed $200 a month for the first time in 2026, reflecting ongoing challenges in managing healthcare expenses.
— via World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended apps based on your readingExplore all apps
Continue Readings
Health Insurer Stocks Reflect Obamacare Subsidy Deal Can Be Reached
PositiveFinancial Markets
Health insurance company stocks experienced a rise on Wednesday, fueled by optimism that the Trump administration and Congress may reach an agreement on extending tax credits for those purchasing insurance through Obamacare. This development reflects ongoing negotiations surrounding healthcare subsidies that are crucial for many Americans.
Stellantis warns this issue could destroy the European auto industry
NegativeFinancial Markets
Stellantis has issued a warning that the European auto industry is facing a critical threat that could lead to its destruction, citing challenges such as regulatory pressures and competition from global markets. This comes as U.S. automakers have adapted to tariffs imposed by the Trump administration, which has focused on taxing auto imports.
Trump Administration Is Taking Billions in Stakes in Firms Like Intel
NeutralFinancial Markets
The Trump administration is investing billions of dollars in acquiring ownership stakes in various companies, including Intel and MP Materials, which operates rare earth mines in California. This trend indicates a significant shift in government involvement in the private sector, with no signs of abating.